Andreas Kogelnik

Source: www.openmedicinefoundation.org

Andreas ("Andy") M. Kogelnik, MD, PhD, is an internal medicine and infectious diseases specialist and the director of the Open Medicine Institute, Mountain View, California, US. His interests are in bioinformatics and genomic medicine and is committed to the study and treatment of ME/CFS and other chronic illnesses.

Education

• MD from Emory University
• PhD in bioengineering from Georgia Tech
• Residency in internal medicine at Stanford University
• Fellowship in infectious diseases at Stanford University

ME/CFS Common Data Element (CDE) Project

Kogelnik is a member of the Immune Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project, sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Research publications on ME/CFS

• 2006, Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue - (Abstract)
• 2011, No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected - (Full text)
• 2013, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Valganciclovir in a Subset of Patients With Chronic Fatigue Syndrome - (Full text)
• 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study - (Full text)

Articles

• 2014, Comments on Progressive Research Year of 2014

Talks and interviews

• May 2011 - Keynote Speaker at the 6th Invest in ME International ME Conference - Speech Title: Strategies for ME Research and Collaboration

• 2011 Conference DVD

• 2012, ME/CFS Alert Episode 23:

The Open Medicine Institute, Part 1,

The Open Medicine Institute, Part 2,

The Open Medicine Institute, Part 3

• 2012, ME/CFS Alert Episode 22:

Interview with Dr. Andreas Kogelnik, Part 1

Interview with Dr. Andreas Kogelnik, Part 2

• 2012, 7th Invest in ME International ME Conference - Strategies for ME Research and Collaboration

• 2012 Conference DVD

• 2013, 8th Invest in ME International ME Conference Keynote Speaker: Strategies for ME Research and Collaboration

• 2013 Conference DVD

• 2014, YouTube - What Works For Chronic Fatigue Syndrome
• 2014, 9th Invest in ME International ME Conference 2014 - No title of talk given

• 2014 Conference DVD

• 2014, ME/CFS Alert Episode 56: Dr. Andreas Kogelnik on the "Real Thrust" of ME/CFS Research
• 2014, ME/CFS Alert Episode 55: Interview with Dr. Andreas Kogelnik
• 17 Feb 2014, Dr. Andreas Kogelnik and Llewellyn King on Sirius XM Radio POTUS Channel 124
• 23 Jan 2014, “The Jim Bohannon Show” with guests, Dr. Andreas Kogelnik, Ryan Prior and Llewellyn King

chronic illness any long-term illness, regardless of the severity. Chronic illnesses are typically incurable, requiring long-term management.

See myalgic encephalomyelitis.

See chronic fatigue syndrome.

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

central nervous system (CNS) - One of the two parts of the human nervous system, the other part being the peripheral nervous system. The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of nerves that travel from the central nervous system into the various organs and tissues of the body.

See National Institutes of Health.

National Institutes of Health (NIH) - A set of biomedical research institutes operated by the U.S. government, under the auspices of the Department of Health and Human Services.

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.